Small and emerging biotechs drive the innovation patients depend on, often investing years in research and development before a treatment ever reaches a patient. That progress relies on the ability to sustain investment through years of clinical trials, uncertainty and setbacks.

Importing other countries’ price controls risks undermining that investment and jeopardizing future treatments - without addressing the role insurers and middlemen play in driving up medicine costs.

It’s time to #SimplifyTheSystem: https://www.bio.org/simplify-the-system